446 related articles for article (PubMed ID: 19149563)
41. Combined targeted ion channel therapy: Can it be an alternative choice for esophageal cancer patients?
Zhang G; Wang X; Xue Q
Med Hypotheses; 2018 Aug; 117():59-62. PubMed ID: 30077199
[TBL] [Abstract][Full Text] [Related]
42. Novel insights into ion channels in cancer stem cells (Review).
Cheng Q; Chen A; Du Q; Liao Q; Shuai Z; Chen C; Yang X; Hu Y; Zhao J; Liu S; Wen GR; An J; Jing H; Tuo B; Xie R; Xu J
Int J Oncol; 2018 Oct; 53(4):1435-1441. PubMed ID: 30066845
[TBL] [Abstract][Full Text] [Related]
43. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
44. Cancer as a channelopathy: ion channels and pumps in tumor development and progression.
Litan A; Langhans SA
Front Cell Neurosci; 2015; 9():86. PubMed ID: 25852478
[TBL] [Abstract][Full Text] [Related]
45. Targeting T-type channels in cancer: What is on and what is off?
Visa A; Alza L; Casas-Benito A; Herreros J; Cantí C
Drug Discov Today; 2022 Mar; 27(3):743-758. PubMed ID: 34838727
[TBL] [Abstract][Full Text] [Related]
46. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy.
Kim R; Tanabe K; Uchida Y; Emi M; Inoue H; Toge T
Cancer Chemother Pharmacol; 2002 Nov; 50(5):343-52. PubMed ID: 12439591
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of cellular synchronization in the vascular wall. Mechanisms of vasomotion.
Matchkov VV
Dan Med Bull; 2010 Oct; 57(10):B4191. PubMed ID: 21040688
[TBL] [Abstract][Full Text] [Related]
48. Potassium channels are a new target field in anticancer drug design.
Villalonga N; Ferreres JC; Argilés JM; Condom E; Felipe A
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):212-23. PubMed ID: 18221064
[TBL] [Abstract][Full Text] [Related]
49. Emerging roles for multifunctional ion channel auxiliary subunits in cancer.
Haworth AS; Brackenbury WJ
Cell Calcium; 2019 Jun; 80():125-140. PubMed ID: 31071485
[TBL] [Abstract][Full Text] [Related]
50. Plasma membrane ion channels and epithelial to mesenchymal transition in cancer cells.
Azimi I; Monteith GR
Endocr Relat Cancer; 2016 Nov; 23(11):R517-R525. PubMed ID: 27619258
[TBL] [Abstract][Full Text] [Related]
51. Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids?
Guéguinou M; Gambade A; Félix R; Chantôme A; Fourbon Y; Bougnoux P; Weber G; Potier-Cartereau M; Vandier C
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2603-20. PubMed ID: 25450343
[TBL] [Abstract][Full Text] [Related]
52. New insights into anti-HER-2 receptor monoclonal antibody research.
Kumar R; Mandal M; Vadlamudi R
Semin Oncol; 2000 Dec; 27(6 Suppl 11):84-91; discussion 92-100. PubMed ID: 11236033
[TBL] [Abstract][Full Text] [Related]
53. Membrane channels and transporters in cancers.
Hervé JC
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2473-6. PubMed ID: 26100062
[No Abstract] [Full Text] [Related]
54. CLC-3 channels in cancer (review).
Hong S; Bi M; Wang L; Kang Z; Ling L; Zhao C
Oncol Rep; 2015 Feb; 33(2):507-14. PubMed ID: 25421907
[TBL] [Abstract][Full Text] [Related]
55. Ion channels and their functional role in vascular endothelium.
Nilius B; Droogmans G
Physiol Rev; 2001 Oct; 81(4):1415-59. PubMed ID: 11581493
[TBL] [Abstract][Full Text] [Related]
56. Voltage-Gated Potassium Channels Kv1.3--Potentially New Molecular Target in Cancer Diagnostics and Therapy.
Teisseyre A; Gąsiorowska J; Michalak K
Adv Clin Exp Med; 2015; 24(3):517-24. PubMed ID: 26467143
[TBL] [Abstract][Full Text] [Related]
57. Ion channels in cancer: future perspectives and clinical potential.
Lang F; Stournaras C
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130108. PubMed ID: 24493756
[TBL] [Abstract][Full Text] [Related]
58. Interplay of Ca
Becchetti A
Curr Top Membr; 2023; 92():15-46. PubMed ID: 38007266
[TBL] [Abstract][Full Text] [Related]
59. Physiology of apoptosis.
Gulbins E; Jekle A; Ferlinz K; Grassmé H; Lang F
Am J Physiol Renal Physiol; 2000 Oct; 279(4):F605-15. PubMed ID: 10997910
[TBL] [Abstract][Full Text] [Related]
60. Side-effects of protein kinase inhibitors on ion channels.
Son YK; Park H; Firth AL; Park WS
J Biosci; 2013 Dec; 38(5):937-49. PubMed ID: 24296897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
